Clinical trial
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
NCT03462680 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
- Lead sponsor
- VA Office of Research and Development
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 28, 2016
- Completion date
- April 23, 2020
- Enrollment
- 47 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease